Director/PDMR Shareholding

One Health Group PLC

13 September 2023

 

One Health Group PLC

PDMR Share Dealing

TR1

13 September 2023

One Health Group PLC ("One Health" or the "Company") announces the following dealings in its shares by Jessica Sellars, who is a person discharging managerial responsibilities in the Company, and by One Health Group Trustees LLP, which is the trustee of the Company's Employee Benefit Trust and a person closely associated with Derek Bickerstaff and Adam Binns and who are directors of the Company, in each case, pursuant to and subsequent to the exercise of options granted under the One Health Group Limited EMI Share Option Plan ("EMI Options), on 11 September 2023:

·    Jessica Sellars exercised EMI Options to purchase 50,000 shares in the Company at a price of 66.7 pence per share and sold 50,000 shares in the Company at a price of 162.5 pence per share;

·    One Health Group Trustees LLP sold 50,000 shares in the Company at a price of 66.7 pence per share and acquired 50,000 shares in the Company at a price of 162.5 pence per share.

Further details of the disclosures made to the Company by Jessica Sellars and One Health Group Trustees LLP are contained in Appendix 1.

Following the above dealings, there is no change to the shareholding of Jessica Sellars in the Company.

Appendix 2 contains disclosure forms relating to One Health Group Trustees LLP which has notified One Health that it controlled over 3% of the Total Voting Rights in the Company and that its percentage interest has changed as a result of its sale and acquisition of shares in the Company outlined above.  Following these dealings, One Health Group Trustees LLP will hold 977,066 shares in the Company, representing approximately 9.30% of the Company's issued share capital.

This announcement contains inside information for the purposes of Article 7 of EU Regulation
596/2014. Which is part of the United Kingdom domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)("UK MAR").

The directors of One Health accept responsibility for this announcement.

Enquiries

One Health Group PLC	Via Square 1 Consulting
Oberon Capital (AQSE Corporate Adviser and Broker) Nick Lovering, Mike Seabrook	020 3179 5300
Square 1 Consulting David Bick	020 7929 5599

Appendix 1

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.	Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Jessica Clare Sellars

2.	Reason for the notification

a)	Position/status:	Director of Operations and Service Development
b	Initial notification/Amendment:	Initial notification

3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name:	One Health Group PLC
b)	LEI:	984500DC689F5BAD8732

4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)	Description of the financial instrument, type of instrument: Identification code:	Ordinary shares of £0.005 each ISIN Code: GB00BNNT0595
b)	Nature of the transaction:	Purchase of share pursuant to the exercise of options; and Sale of shares
c)	Price(s) and Volume (s):	Purchase price(s). 66.7p Volume(s): 50,000 Sale price(s). 162.5p Volume(s): 50,000
d)	Aggregated Information: Aggregated volume: Price:	N/A
e)	Date of the transaction:	11 September 2023
f)	Place of the transaction	Aquis (AQSE)

1.	Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

One Health Group Trustees LLP

2.	Reason for the notification

a)	Position/status:	Corporate Trustee of EBT
b	Initial notification/Amendment:	Initial notification

3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name:	One Health Group PLC
b)	LEI:	984500DC689F5BAD8732

4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)	Description of the financial instrument, type of instrument: Identification code:	Ordinary shares of £0.005 each ISIN Code: GB00BNNT0595
b)	Nature of the transaction:	Sale of shares and Purchase of shares
c)	Price(s) and Volume (s):	Sale price(s). 66.7p Volume(s): 50,000 Purchase price(s). 162.5p Volume(s): 50,000
d)	Aggregated Information: Aggregated volume: Price:	N/A
e)	Date of the transaction:	11 September 2023
f)	Place of the transaction	Aquis (AQSE)

Appendix 2

Disclosure forms re major share holdings

TR-1: standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:			ONE HEALTH GROUP PLC 131 Psalter Lane Sheffield S11 8UX LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
Name			One Health Group Trustees LLP
City and country of registered office (if applicable)			Sheffield, South Yorkshire, England
4. Full name of shareholder(s) (if different from 3.) v
Name			As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached vi:			11th September 2023
6. Date on which issuer notified (DD/MM/YYYY):			11th September 2023
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached	8.82%			8.82%	927,066
Position of previous notification (if applicable)	9.30%			9.30%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ix					% of voting rights
		Direct (DTR5.1)		Indirect  (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB00BNNT0595		927,066					8.82%
SUBTOTAL 8. A		927,066					8.82%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date x	Exercise/ Conversion Period xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date x		Exercise/ Conversion Period xi		Physical or cash Settlement xii			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii				x
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Name xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi

Place of completion	Aquis (AQSE)
Date of completion	11 September 2023

TR-1: standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:			ONE HEALTH GROUP PLC 131 Psalter Lane Sheffield S11 8UX LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
Name			One Health Group Trustees LLP
City and country of registered office (if applicable)			Sheffield, South Yorkshire, England
4. Full name of shareholder(s) (if different from 3.) v
Name			As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached vi:			11th September 2023
6. Date on which issuer notified (DD/MM/YYYY):			11th September 2023
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached	9.30%			9.30%	977,066
Position of previous notification (if applicable)	8.82%			8.82%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ix					% of voting rights
		Direct (DTR5.1)		Indirect  (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB00BNNT0595		977,066					9.30%
SUBTOTAL 8. A		977,066					9.30%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date x	Exercise/ Conversion Period xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date x		Exercise/ Conversion Period xi		Physical or cash Settlement xii			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii				x
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Name xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi

Place of completion	Aquis (AQSE)
Date of completion	11 September 2023

 

END